1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with diazepam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukura, H; Igarashi, M; Komiya, Y | 1 |
| Enomoto, Y; Iwama, T; Yamada, K; Yoshimura, S | 1 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and diazepam
| Article | Year |
|---|---|
Signaling pathway downstream of GABAA receptor in the growth cone.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Animals, Newborn; Axons; Binding Sites; Calcium; Chlorides; Diazepam; Fetus; gamma-Aminobutyric Acid; GTPase-Activating Proteins; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Models, Neurological; Muscimol; Myristoylated Alanine-Rich C Kinase Substrate; Neurites; Picrotoxin; Prosencephalon; Proteins; Rats; Rats, Wistar; Receptors, GABA-A; Signal Transduction; Verapamil | 1996 |
Convulsion during intra-arterial infusion of fasudil hydrochloride for the treatment of cerebral vasospasm following subarachnoid hemorrhage.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Aged; Aged, 80 and over; Anticonvulsants; Catheterization; Cerebral Arteries; Diazepam; Drug Administration Routes; Female; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Middle Aged; Retrospective Studies; Seizures; Subarachnoid Hemorrhage; Time Factors; Vasodilator Agents; Vasospasm, Intracranial | 2010 |